BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

279 related articles for article (PubMed ID: 9441061)

  • 1. Primary resistance to anti-tuberculosis drugs in Addis Ababa, Ethiopia.
    Demissie M; Gebeyehu M; Berhane Y
    Int J Tuberc Lung Dis; 1997 Feb; 1(1):64-7. PubMed ID: 9441061
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary drug resistance in newly diagnosed smear positive tuberculosis patients in Addis Ababa, Ethiopia.
    Asmamaw D; Seyoum B; Makonnen E; Atsebeha H; Woldemeskel D; Yamuah L; Addus H; Aseffa A
    Ethiop Med J; 2008 Oct; 46(4):367-74. PubMed ID: 19271401
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-tuberculosis drug resistance among retreatment patients seen at St Peter Tuberculosis Specialized Hospital.
    Meskel DW; Abate G; Lakew M; Goshu S; Aseffa A
    Ethiop Med J; 2008 Jul; 46(3):219-25. PubMed ID: 19271385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug resistance in tuberculosis in Delhi: a 2 year profile (2001--2002).
    Negi SS; Gupta S; Lal S
    J Commun Dis; 2003 Jun; 35(2):74-81. PubMed ID: 15562952
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Resistance of mycobacterial tuberculosis complex to the main antibacillary agent in Yaounde, Cameroon].
    Bercion R; Kuaban C
    Bull Soc Pathol Exot; 1998; 91(3):199-202. PubMed ID: 9773189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug resistance in Mycobacterium tuberculosis strains isolated from re-treatment cases of pulmonary tuberculosis in Ethiopia: susceptibility to first-line and alternative drugs.
    Abate G; Miörner H; Ahmed O; Hoffner SE
    Int J Tuberc Lung Dis; 1998 Jul; 2(7):580-4. PubMed ID: 9661826
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Drug-resistant tuberculosis in Budapest.
    Fodor T; Vadász I; Lõrinczi I
    Int J Tuberc Lung Dis; 1998 Sep; 2(9):732-5. PubMed ID: 9755927
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pattern of mycobacterial resistance to four anti-tuberculosis drugs in pulmonary tuberculosis patients in the state of Qatar after the implementation of DOTS and a limited expatriate screening programme.
    Al-Marri MR
    Int J Tuberc Lung Dis; 2001 Dec; 5(12):1116-21. PubMed ID: 11769769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance to the first line of antitubercular regimen (a preliminary report).
    Varaiya A; Gogate A
    Indian J Public Health; 1998; 42(4):126-30. PubMed ID: 10389525
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of primary and acquired resistance of Mycobacterium tuberculosis to antituberculosis drugs in Benin after 12 years of short-course chemotherapy.
    Trébucq A; Anagonou S; Gninafon M; Lambregts K; Boulahbal F
    Int J Tuberc Lung Dis; 1999 Jun; 3(6):466-70. PubMed ID: 10383057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quality assurance programme for drug susceptibility testing of Mycobacterium tuberculosis in the WHO/IUATLD Supranational Laboratory Network: first round of proficiency testing.
    Laszlo A; Rahman M; Raviglione M; Bustreo F
    Int J Tuberc Lung Dis; 1997 Jun; 1(3):231-8. PubMed ID: 9432369
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevalence of initial drug resistance to M. tuberculosis in new sputum positive RNTCP patients.
    Dhingra VK; Rajpal S; Bhalla P; Yadav A; Jain SK; Hanif M
    J Commun Dis; 2003 Jun; 35(2):82-9. PubMed ID: 15562953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug-resistant tuberculosis in Ethiopia: problem scenarios and recommendation.
    Abate G
    Ethiop Med J; 2002 Jan; 40(1):79-86. PubMed ID: 12240570
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Primary drug resistance to anti-tuberculosis drugs in major towns of Amhara region, Ethiopia.
    Yimer SA; Agonafir M; Derese Y; Sani Y; Bjune GA; Holm-Hansen C
    APMIS; 2012 Jun; 120(6):503-9. PubMed ID: 22583363
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Global surveillance for antituberculosis-drug resistance, 1994-1997. World Health Organization-International Union against Tuberculosis and Lung Disease Working Group on Anti-Tuberculosis Drug Resistance Surveillance.
    Pablos-Méndez A; Raviglione MC; Laszlo A; Binkin N; Rieder HL; Bustreo F; Cohn DL; Lambregts-van Weezenbeek CS; Kim SJ; Chaulet P; Nunn P
    N Engl J Med; 1998 Jun; 338(23):1641-9. PubMed ID: 9614254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-tuberculosis drug resistance in Portugal.
    Antunes ML; Aleixo-Dias J; Antunes AF; Pereira MF; Raymundo E; Rodrigues MF
    Int J Tuberc Lung Dis; 2000 Mar; 4(3):223-31. PubMed ID: 10751067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multicenter transversal study of tuberculosis and drug resistance in Madrid (October 1993-April 1994)].
    Med Clin (Barc); 1996 Jan; 106(1):1-6. PubMed ID: 8750533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug resistance among Mycobacterium tuberculosis isolates in Lebanon.
    Hamze MM; Araj GF
    Int J Tuberc Lung Dis; 1997 Aug; 1(4):314-8. PubMed ID: 9432386
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of drug resistance in previously treated tuberculosis patients in Gujarat, India.
    Shah AR; Agarwal SK; Shah KV
    Int J Tuberc Lung Dis; 2002 Dec; 6(12):1098-101. PubMed ID: 12546118
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High prevalence of multidrug-resistant tuberculosis in Zunyi, Guizhou Province of China.
    Chen L; Li N; Liu M; Zhang J; Zhang H
    J Antimicrob Chemother; 2011 Oct; 66(10):2435-7. PubMed ID: 21795258
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 14.